Measurement of 25-hydroxyvitamin D in the clinical laboratory: Current procedures, performance characteristics and limitations

Steroids

Volumn 75, Issue 7, 2010, Pages 477-488

  Wallace, A M ^a   Gibson, S ^b   de la Hunty, A ^b   Lamberg Allardt, C ^c   Ashwell, M ^b  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

^b Ashwell Associates   (United Kingdom)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

25 Hydroxyvitamin D; Chromatography; Immunoassay; Mass spectrometry; Methodology; Review

Indexed keywords

25 HYDROXYERGOCALCIFEROL; 25 HYDROXYVITAMIN D; CALCIFEDIOL;

ACCURACY; ANALYTIC METHOD; BLOOD ANALYSIS; CHEMOLUMINESCENCE; CLINICAL LABORATORY; ENZYME IMMUNOASSAY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTERMETHOD COMPARISON; LABORATORY AUTOMATION; LABORATORY TEST; MASS SPECTROMETRY; PROCESS DEVELOPMENT; QUALITY CONTROL; QUANTITATIVE ANALYSIS; RADIOIMMUNOASSAY; REVIEW; SENSITIVITY AND SPECIFICITY; SEPARATION TECHNIQUE; STANDARD; SYSTEMATIC ERROR; VITAMIN D DEFICIENCY; VITAMIN METABOLISM;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, LIQUID; CLINICAL LABORATORY TECHNIQUES; HUMANS; IMMUNOASSAY; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; TANDEM MASS SPECTROMETRY; VITAMIN D;

EID: 77951097205     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.steroids.2010.02.012     Document Type: Review

References (63)

1. Seamans K.M., and Cashman K.D. Existing and potentially novel functional markers of vitamin D status: a systematic review. Am J Clin Nutr 89 (2009) 1997S-2008S
2. Department of Health. Nutrition and bone health: with particular reference to calcium and vitamin D. Report on Health and Social Subjects vol. 49 (1998), The Stationery Office, London, United Kingdom
3. Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 22 (2001) 477-501
4. Ooms M.E., Lips P., Roos J.C., van der Vijgh W.J., Popp-Snijders C., Bezemer P.D., et al. Vitamin D status and sex hormone binding globulin: determinants of bone turnover and bone mineral density in elderly women. J Bone Miner Res 10 (1995) 1177-1184
5. Bischoff-Ferrari H.A., Giovannucci E., Willett W.C., Dietrich T., and Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 84 (2006) 18-28
6. Holick M.F. Vitamin D status: measurement, interpretation, and clinical application. Ann Epidemiol 19 (2009) 73-78
7. Carter G.D., Carter R., Jones J., and Berry J. How accurate are assays for 25-hydroxyvitamin D? Data from the international vitamin D external quality assessment scheme. Clin Chem 50 (2004) 2195-2197
8. Hollis B.W. Comparison of commercially available (125)I-based RIA methods for the determination of circulating 25-hydroxyvitamin D. Clin Chem 46 (2000) 1657-1661
9. Glendenning P., Noble J.M., Taranto M., Musk A.A., McGuiness M., Goldswain P.R., et al. Issues of methodology, standardization and metabolite recognition for 25-hydroxyvitamin D when comparing the DiaSorin radioimmunoassay and the Nichols Advantage automated chemiluminescence protein-binding assay in hip fracture cases. Anal Clin Biochem 40 (2003) 546-551
10. Glendenning P., Taranto M., Noble J.M., Musk A.A., Hammond C., Goldswain P.R., et al. Current assays overestimate 25-hydroxyvitamin D3 and underestimate 25-hydroxyvitamin D2 compared with HPLC: need for assay-specific decision limits and metabolite-specific assays. Anal Clin Biochem 43 (2006) 23-30
11. Carter G.D., Jones J.C., and Berry J.L. The anomalous behaviour of exogenous 25-hydroxyvitamin D in competitive binding assays. J Steroid Biochem Mol Biol 103 (2007) 480-482
12. Ersfeld D.L., Rao D., Sudhaker, Body J., Jacques, Sackrison Jr. J.L., Miller A.B., Parikh N., et al. Analytical and clinical validation of the 25 OH vitamin D assay for the LIAISON automated analyzer. Clin Biochem 37 (2004) 867-874
13. Turpeinen U., Hohenthal U., Stenman U., and Håkan. Determination of 25-hydroxyvitamin D in serum by HPLC and immunoassay. Clin Chem 49 (2003) 1521-1524
14. Maunsell Z., Wright D.J., and Rainbow S.J. Routine isotope-dilution liquid chromatography-tandem mass spectrometry assay for simultaneous measurement of the 25-hydroxy metabolites of vitamins D2 and D3. Clin Chem 51 (2005) 1683-1690
15. Saenger A.K., Laha T.J., Bremner D.E., and Sadrzadeh S.M.H. Quantification of serum 25-hydroxyvitamin D2 and D3 using HPLC-tandem mass spectrometry and examination of reference intervals for diagnosis of vitamin D deficiency. Am J Clin Pathol 125 (2006) 914-920
16. Chen H., McCoy L.F., Schleicher R.L., and Pfeiffer C.M. Measurement of 25-hydroxyvitamin D3 25OHD3 and 25-hydroxyvitamin D2 25OHD2 in human serum using liquid chromatography-tandem mass spectrometry and its comparison to a radioimmunoassay method. Clin Chim Acta 391 (2008) 6-12
17. Souberbielle J., Claude, Fayol V., Sault C., Lawson B., Ethel, et al. Assay-specific decision limits for two new automated parathyroid hormone and 25-hydroxyvitamin D assays. Clin Chem 51 (2005) 395-400
18. Ibrahim F., Parmentier C., and Boudou P. Divergence in classification of 25-hydroxyvitamin D status with respect to immunoassays. Clin Chem 53 (2007) 363-364
19. Roth H., Jürgen, Schmidt G., Heinrich, Weber H., and Niederau C. Accuracy and clinical implications of seven 25-hydroxyvitamin D methods compared with liquid chromatography-tandem mass spectrometry as a reference. Anal Clin Biochem 45 (2008) 153-159
20. Hyppönen E., Turner S., Cumberland P., Power C., and Gibb I. Serum 25-hydroxyvitamin D measurement in a large population survey with statistical harmonization of assay variation to an international standard. J Clin Endocrinol Metab 92 (2007) 4615-4622
21. Kimball S.M., and Vieth R. A comparison of automated methods for the quantitation of serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D. Clin Biochem 40 (2007) 1305-1310
22. Knox S., Harris J., Calton L., and Wallace A.M. A simple automated solid-phase extraction procedure for measurement of 25-hydroxyvitamin D3 and D2 by liquid chromatography-tandem mass spectrometry. Anal Clin Biochem 46 (2009) 226-230
23. Leino A., Turpeinen U., and Koskinen P. Automated measurement of -OH vitamin D3 on the Roche Modular E170 analyzer. Clin Chem 54 (2008) 2059-2062
24. Alvarez J.C., and De Mazancourt P. Rapid and sensitive high-performance liquid chromatographic method for simultaneous determination of retinol, alpha-tocopherol, 25-hydroxyvitamin D3 and 25-hydroxyvitamin D2 in human plasma with photodiode-array ultraviolet detection. J Chromatogr B Biomed Sci Appl 755 (2001) 129-135
25. Brunetto M.R., Obando M.A., Gallignani M., Alarcón O.M., Nieto E., Salinas R., et al. HPLC determination of Vitamin D3 and its metabolite in human plasma with on-line sample cleanup. Talanta 64 (2004) 1364-1370
26. Jakobsen J., Bysted A., Andersen R., Bennett T., Brot C., Bügel S., et al. Vitamin D status assessed by a validated HPLC method: within and between variation in subjects supplemented with vitamin D3. Scan J Clin Lab Invest 69 (2009) 190-197
27. Mata-Granados J.M., Quesada Gomez J.M., and Luque de Castro M.D. Fully automatic method for the determination of fat soluble vitamins and vitamin D metabolites in serum. Clin Chim Acta 403 (2009) 126-130
28. Lensmeyer G.L., Wiebe D.A., Binkley N., and Drezner M.K. HPLC method for 25-hydroxyvitamin D measurement: comparison with contemporary assays. Clin Chem 52 (2006) 1120-1126
29. Aronov P.A., Hall L.M., Dettmer K., Stephensen C.B., and Hammock B.D. Metabolic profiling of major vitamin D metabolites using Diels-Alder derivatization and ultra-performance liquid chromatography-tandem mass spectrometry. Anal Bioanal Chem 391 (2008) 1917-1930
30. Tsugawa N., Suhara Y., Kamao M., and Okano T. Determination of 25-hydroxyvitamin D in human plasma using high-performance liquid chromatography--tandem mass spectrometry. Anal Chem 77 (2005) 3001-3007
31. Vogeser M., Kyriatsoulis A., Huber E., and Kobold U. Candidate reference method for the quantification of circulating 25-hydroxyvitamin D3 by liquid chromatography-tandem mass spectrometry. Clin Chem 50 (2004) 1415-1417
32. Mata-Granados J.M., Luque D., Castro M.D., and Quesada J.M. Fully automated method for the determination of 24,25OH2 and 25OH D3 hydroxyvitamins, and vitamins A and E in human serum by HPLC. J Pharma Biomed Anal 35 (2004) 575-582
33. Yates A., Marie, Bowron A., Calton L., Heynes J., Field H., Rainbow S., et al. Interlaboratory variation in 25-hydroxyvitamin D2 and 25-D3 is significantly improved if common calibration material is used. Clin Chem 54 (2008) 2082-2084
34. Carter G.D., and Jones J.C. Use of a common standard improves the performance of liquid chromatography-tandem mass spectrometry methods for serum 25-hydroxyvitamin-D. Anal Clin Biochem 46 (2009) 79-81
35. Zerwekh J.E. The measurement of vitamin D: analytical aspects. Anal Clin Biochem 41 (2004) 272-281
36. Hollis B.W. Editorial: The determination of circulating 25-hydroxyvitamin D: no easy task. J Endocrinol Metab 89 (2004) 3149-3151
37. Binkley N., Krueger D., Cowgill C.S., Plum L., Lake E., Hansen K.E., et al. Assay Variation Confounds the Diagnosis of Hypovitaminosis D: A Call for Standardization. J Clin Endocrinol Metab 89 (2004) 3152-3157
38. Wootton A.M. Improving the measurement of 25-hydroxyvitamin D. Clinical Clin Biochem Rev 26 (2005) 33-36
39. Binkley N. Vitamin D: clinical measurement and use. J Muscu Neur Inter 6 (2006) 338-340
40. Kolatkar N.S., and LeBoff M.S. Analytic challenges in monitoring vitamin D therapy. Am J Clin Pathol 127 (2007) 472-473
41. Lips P. Relative value of 25OHD and 1,25OH2D measurements. J Bone Min Res 22 (2007) 1668-1671
42. Beastall G., and Rainbow S. Vitamin D reinvented: implications for clinical chemistry. Clin Chem 54 (2008) 630-632
43. Binkley N., Krueger D., Gemar D., and Drezner M.K. Correlation among 25-hydroxy-vitamin D assays. J Clin Endocrinol Metab 93 (2008) 1804-1808
44. Brannon P.M., Yetley E.A., Bailey R.L., and Picciano M.F. Overview of the conference "Vitamin D and Health in the 21st Century: an Update". Am J Clin Nutr 88 (2008) 483S-490S
45. Jones B.J., and Twomey P.J. Issues with vitamin D in routine clinical practice. Rheumatology (Oxford England) 47 (2008) 1267-1268
46. Singh R.J. Are clinical laboratories prepared for accurate testing of 25-hydroxy vitamin D?. Clin Chem 54 (2008) 221-223
47. Fraser W.D. Standardization of vitamin D assays: art or science?. Anal Clin Biochem 46 (2009) 3-4
48. Blocki J., Fenske J., Bobba G., and Walter J. Measurement of 25OHD spiked serum samples have no clinical relevance. In Proceedings of the 14th Workshop on Vitamin D. Brugge, Belgium (2009)
49. Horst R. Exogenous vs. endogenous recovery of 25-hydroxyvitamin D2 and D3 in human samples using HPLC and the Diasorin Liaison Total D assay. In Proceedings of the 14th Workshop on Vitamin D. Brugge, Belgium (2009)
50. Ozzard A., Hear G., Morrison G., and Hoskin M. Vitamin D deficiency treated by consuming UVB-irradiated mushrooms. Br J Gen Pract 58 (2008) 644-645
51. Mattila P.H., Piironen V.I., Uusi-Rauva E.J., and Koivistoinen P.E. Vitamin D contents in edible mushrooms. J Agric Food Chem 42 (1994) 2449-2453
52. Outila T., Mattila P., Piironen V., and Lamberg-Allardt C. Bioavailability of vitamin D from wild edible mushrooms (Cantharellus tubaeformis) as measured with a human bioassay. Am J Clin Nutr 69 (1999) 95-98
53. Zerwekh J.E. Blood biomarkers of vitamin D status. Am J Clin Nutr 87 (2008) 1087S-1091S
54. Hollis B.W. Assessment of vitamin D status and definition of a normal circulating range of 25-hydroxyvitamin D. Current Opt Endocrinol Diabetes Obesity 15 (2008) 489-494
55. Cavalier E., Wallace A., Knox S., Mistretta V.I., Cormier C., and Souberbielle J.C. Serum vitamin D measurement may not reflect what you give to your patients. J Bone Min Res 23 (2008) 1864-1865
56. Costelloe S.J., Woolman E., Rainbow S., Stratiotis L.O.G.G., Whiting S., et al. Is high-throughput measurement of 25-hydroxyvitamin D3 without 25-hydroxyvitamin D2 appropriate for routine clinical use?. Anal Clin Biochem 46 (2009) 86-87
57. Vieth R. Problems with direct 25-hydroxyvitamin D assays, and the target amount of vitamin D nutrition desirable for patients with osteoporosis. Osteoporosis Int 11 (2000) 635-636
58. Singh R.J., Taylor R.L., Reddy G., Satyanarayana, and Grebe S.K.G. C-3 epimers can account for a significant proportion of total circulating 25-hydroxyvitamin D in infants, complicating accurate measurement and interpretation of vitamin D status. J Clin Endocrinol Metab 91 (2006) 3055-3061
59. Elder P.A., Lewis J.G., King R.I., and Florkowski C.M. An anomalous result from gel tubes for vitamin D. Clin Chim Acta 410 (2009) 95
60. Annesley T.M. Ion suppression in mass spectrometry. Clin Chem 49 7 (2003) 1041-1044
61. Hollis B.W. Measuring 25-hydroxyvitamin D in a clinical environment: challenges and needs. Am J Clin Nutr 88 (2008) 507S-510S
62. Hollis B.W., and Horst R.L. The assessment of circulating 25OHD and 1,25OH2D: where we are and where we are going. J Steroid Biochem Molec Biol 103 (2007) 473-476
63. Jones G., Horst R., Carter G., and Makin H.Lj. Contemporary diagnosis and treatment of vitamin D-related disorders. J Bone Min Res 22 Suppl. 2 (2007) V11-5